The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Never trust the P&D merchants on twitter, on invest on your own research. I only follow a few, Stock Surfer has been going on about amigo for a few weeks. They seem to think it will go to £1.20. One of the few that tend to call it a few weeks in advance, rather than the ones that appear when the SP has done 20% already.
8.10
it's very much a waiting game, some will sell at 12p some at £1, some will wait and hold and take dividends each and every year.
Think some big buys will show up soon.
At 10% he can force a vote. JB knows what he's doing.
Personal Experience
My mum broke down a few years back. She showed me her debt that had racked up with payday loan sharks. 100s% interest from the likes of payday UK, cash genie etc. I worked through it with her. I managed to clear some via my own Personal savings. We then consolidated the rest via amigo to build her credit back up and also break the debt cycle. For me Amigo helped take out the bad from the market place. They helped people get out the most horrendous predicaments.
I'd check your overdraft rates. 49% is the going rate for us all.
Steve, you also make the argument that poor people are dumb and can't make their own choices. Thankfully, in you, they have such a morale guardian to look after their needs.
Tory that's shouldn't be allowed shares? Sounds like you're the elitist. Also a bit hypocritical as investigating in shares is part of the capitalism machine. A true Liberal wouldn't invest in a business. If you feel so badly about the business model then you should have done your homework prior to investing. No hope with some people.
You disagree that the poorest in society should have access to credit?
414k buy???
just read their rns. Big drop no doubt, feel for the traders who will have kept open positions over the weekend. Long term, like amigo, they will be fine. Guarantor loans are only one aspect of their business. Suprised we haven't had an RNS yet regards CEO.
If we get half the volume of Friday, we'll be just fine.
If things are going as well as they look, retained profits building and cash reserves too, they could always declare a dividend. That would see the share price rise substantially from these levels.
Plenty of upside here, try and hold for the medium long term. £2 target will need revising fairly soon. Interesting to see how the C4XD molecule will develop too.
Look at those buys
An update on FDA meeting due, they would have had to let the market know if it had been delayed.
An update on the progress of Ureka, also their involvement in the French consortium put together by the French government.
An update on BioAMP-B, which given its safety profile, could be a market leader!
Funding - they have a 200m revolving facility guys. read the financials please.
Q1 2019 came out on the 5th.
Assume earnings call PM, then release tomorrow same as last year???
RNS?